Donghai Jiang

China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Luteolin Induces GPX4-dependent Ferroptosis and Enhances Immune Activation in Colon Cancer.

Luteolin Induces GPX4-dependent Ferroptosis and Enhances Immune Activation in Colon Cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 24, 2025

Resveratrol restrains colorectal cancer metastasis by regulating miR-125b-5p/TRAF6 signaling axis.

Resveratrol restrains colorectal cancer metastasis by regulating miR-125b-5p/TRAF6 signaling axis.

Journal: American journal of cancer research
Published: December 26, 2023

DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy.

DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy.

Journal: International journal of biological sciences
Published: October 31, 2022

Pralatrexate mediates effective killing of gemcitabine-resistant pancreatic cancer: role of mTOR/4E-BP1 signal pathway.

Pralatrexate mediates effective killing of gemcitabine-resistant pancreatic cancer: role of mTOR/4E-BP1 signal pathway.

Journal: Heliyon
Published: August 24, 2022

The contributions of extrachromosomal DNA elements in neoplasm progression.

The contributions of extrachromosomal DNA elements in neoplasm progression.

Journal: American journal of cancer research
Published: November 27, 2020

AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest.

AG-1024 Sensitizes Sorafenib-Resistant Hepatocellular Carcinoma Cells to Sorafenib via Enhancing G1/S Arrest.

Journal: OncoTargets and therapy
Published: October 29, 2020

Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy.

Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy.

Journal: American journal of translational research
Published: September 28, 2019

LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells.

LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells.

Journal: American journal of cancer research
Published: September 10, 2019

NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.

NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.

Journal: International journal of biological sciences
Published: August 23, 2019

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer.

COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer.

Journal: International journal of oncology
Published: February 02, 2019

Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.

Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.

Journal: Journal of translational medicine
Published: October 22, 2018

Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma.

Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma.

Journal: American journal of cancer research
Published: April 10, 2018
Showing 1-12 of 20

Last Updated: 09/26/2026